
The regulatory stakes at innovator CMO sites have never been higher.
This white paper draws on Redica's analysis of 168 CMO sites, as well as perspectives from quality leaders at Thermo Fisher/Patheon, Fujifilm Diosynth, Sentrx, and Boehringer Ingelheim. These leaders and experts cover what is actually driving inspection risk today, and what the highest-performing sponsor-CMO relationships do differently.
If your governance structure is built for when things go wrong rather than before they do, this white paper was written for your team.
